Qyuns Therapeutics Announces NDA Acceptance for Crusekitug in Treating Ankylosing Spondylitis Qyuns Therapeutics: New Drug Application for Crusekitug Accepted by NMPA Key Points from the Announcement Qyuns Therapeutics Co., Ltd. announced that the National...